1. Home
  2. GNFT vs EIC Comparison

GNFT vs EIC Comparison

Compare GNFT & EIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNFT
  • EIC
  • Stock Information
  • Founded
  • GNFT 1999
  • EIC N/A
  • Country
  • GNFT France
  • EIC United States
  • Employees
  • GNFT N/A
  • EIC N/A
  • Industry
  • GNFT Biotechnology: Biological Products (No Diagnostic Substances)
  • EIC Finance/Investors Services
  • Sector
  • GNFT Health Care
  • EIC Finance
  • Exchange
  • GNFT Nasdaq
  • EIC Nasdaq
  • Market Cap
  • GNFT 214.5M
  • EIC 341.0M
  • IPO Year
  • GNFT 2019
  • EIC 2019
  • Fundamental
  • Price
  • GNFT $3.89
  • EIC $13.74
  • Analyst Decision
  • GNFT Strong Buy
  • EIC Strong Buy
  • Analyst Count
  • GNFT 1
  • EIC 1
  • Target Price
  • GNFT $13.00
  • EIC $17.50
  • AVG Volume (30 Days)
  • GNFT 4.2K
  • EIC 291.4K
  • Earning Date
  • GNFT 04-24-2025
  • EIC 08-05-2025
  • Dividend Yield
  • GNFT N/A
  • EIC 17.47%
  • EPS Growth
  • GNFT N/A
  • EIC N/A
  • EPS
  • GNFT 0.03
  • EIC 0.55
  • Revenue
  • GNFT $73,187,701.00
  • EIC $51,224,692.00
  • Revenue This Year
  • GNFT $15.98
  • EIC $42.67
  • Revenue Next Year
  • GNFT N/A
  • EIC $29.16
  • P/E Ratio
  • GNFT $125.30
  • EIC $24.91
  • Revenue Growth
  • GNFT 105.01
  • EIC 68.61
  • 52 Week Low
  • GNFT $2.55
  • EIC $12.63
  • 52 Week High
  • GNFT $6.42
  • EIC $16.71
  • Technical
  • Relative Strength Index (RSI)
  • GNFT 47.15
  • EIC 56.13
  • Support Level
  • GNFT $3.61
  • EIC $13.32
  • Resistance Level
  • GNFT $3.95
  • EIC $13.83
  • Average True Range (ATR)
  • GNFT 0.16
  • EIC 0.19
  • MACD
  • GNFT -0.03
  • EIC 0.09
  • Stochastic Oscillator
  • GNFT 44.87
  • EIC 86.36

About GNFT GENFIT S.A.

Genfit SA is a biotechnology company focused on metabolic and inflammatory diseases, with a particular focus on the liver and gastroenterology. The company's research and development activity relies on its expertise in modulating gene expression through nuclear receptors. Genfit utilizes acquisitions, strategic alliances, and licensing agreements in order to fund the further development of its products. It has one segment the research and development of medicines and diagnostic solutions, the marketing of which depends on the success of the clinical development phase.

About EIC Eagle Point Income Company Inc.

Eagle Point Income Co Inc is a closed-end management investment company. Its primary investment objective is to generate high current income, with a secondary objective to generate capital appreciation. The Company seeks to achieve its investment objectives by investing in junior debt tranches of collateralized loan obligations, or "CLOs," that are collateralized by a portfolio consisting of below-investment grade U.S. senior secured loans with a large number of distinct underlying borrowers across various industry sectors.

Share on Social Networks: